Sibylla Biotech is a preclinical biotechnology company developing small molecule degraders with a mechanism of action in the pharmaceutical sector
Sibylla Biotech is a preclinical biotechnology company developing small molecule degraders with a mechanism of action in the pharmaceutical sector. The company works on therapeutics by using computer simulations and AI methods to create compounds that target and degrade specific proteins involved in various diseases.